Eli Lilly’s Zepbound, on top of older drug, reduced psoriatic arthritis symptoms
[ad_1] Eli Lilly said Thursday that adding its weight loss drug Zepbound on top of its immunology therapy Taltz helped obese patients with an autoimmune condition that causes joint pain more than Taltz did alone. The data suggest the GLP-1 drug Zepbound, which has already been shown to help with obesity and sleep apnea, among…